Even though more than 109 million kids in developing countries have been vaccinated with pneumococcal conjugate vaccine (PCV), approximately half of the world’s children are still not receiving PCV.
By Keith Klugman (Global Health NOW)
There is something that you and I both do 23,000 times each day.
Breathe. Inhale life-sustaining oxygen, without which we’d only survive a handful of minutes. Breathing shouldn’t be a privilege. But it is. Around the world, pneumonia makes breathing impossible for too many, taking the lives of 920,000 children annually—a life every 2 minutes. That’s more than malaria and diarrhea combined.
When I first began my career, children dying from pneumonia seemed unavoidable. A pneumonia vaccine was not yet available and antibiotics were expensive and hard to access. This left kids vulnerable to disease, like those I treated in South Africa as a medical student. Every day, I listened to the crackling chests of young children as they fought for air.
Now, 25 years later, pneumonia is not only curable, but largely preventable. With the help of Gavi, more than 109 million kids in developing countries have been vaccinated with pneumococcal conjugate vaccine (PCV), which protects them against the leading cause of pneumonia deaths. Antibiotics are cheaper and more widely available. And even life-sustaining oxygen therapy is becoming more readily available, thanks to the WHO’s recent decision to list oxygen on the Essential Medicines List.
Yet, overall progress remains intolerably slow compared to other childhood diseases. While pneumonia deaths have dropped by nearly 50% since 2000, too many kids still don’t have access to vaccines that can prevent the disease from taking hold in the first place. Approximately 1/2 of the world’s children are still not receiving PCV. This leaves kids immediately vulnerable, and in the longer-term impacts the effectiveness of antibiotics as more childhood infections results in increased antibiotic use.
While I think about these concerns often, around World Pneumonia Day on November 12 (which happens to fall during World Antibiotic Awareness week) I pause to consider how far we have come, and how we can move forward so no child dies a preventable death from pneumonia.
Most urgently, PCV must become more affordable so it can reach every child who needs it. Tremendous financial investment in Gavi, the Vaccine Alliance, in the last decade has enabled PCV to be priced at $9 per child, so it can begin to reach children in the poorest countries in the world. But, we believe that to reach every child, pharmaceutical companies, governments and aid donors should commit to getting this cost below $5.
Additionally, when kids do fall ill, governments must ensure that oxygen therapy and antibiotics are readily available. We must continue to build awareness about pneumonia, its symptoms and its treatments. Thanks to Save the Children’s recent “Fighting for Breath” report, there is a clear path forward to focus efforts to saving more than 5 million lives from pneumonia by 2030.
Read the complete story at Global Health NOW
- OPINION: How to Address Autism in Ethiopia and Other Low-income Nations
- Babies and Mothers Worldwide Failed by Lack of Investment in Breastfeeding
- Aliko Dangote and Bill Gates: Why We are Hopeful About Improving Health in Africa
- Historic Commitment from African Heads of State to Advance Immunization in the Continent
- Ohio State University Global One Health Initiative Opens Eastern Africa Regional Office in Addis Ababa